Azar Shahraz

Azar Shahraz is Group Director of Clinical Pharmacology at AbbVie, where she leads clinical pharmacology strategy for oncology solid tumor programs. With extensive experience spanning oncology, RNA therapeutics, pharmacometrics, PBPK modelling, and quantitative systems pharmacology, she has held leadership roles at AstraZeneca, Alnylam Pharmaceuticals, and Simulations Plus, contributing to the development and regulatory advancement of innovative therapies across multiple modalities. Her expertise spans model-informed drug development, translational science, and the application of quantitative approaches to accelerate decision-making throughout drug development.